Metallothionein I+II expression as an early sign of chronic relapsing experimental autoimmune encephalomyelitis in rats

Current Aging Science

Volumn 6, Issue 1, 2013, Pages 37-44

  Jakovac, Hrvoje ^a   Tota, Marin ^a   Grebic, Damir ^a   Grubic Kezele, Tanja ^a   Barac Latas, Vesna ^a   Ines Mrakovcic Sutic, ^a   Milin, Cedomila ^a   Radosevic Stasic, Biserka ^a  

^a UNIVERSITY OF RIJEKA   (Croatia)

Author keywords

Chronic relapsing experimental autoimmune encephalomyelitis; CNS; Liver; Metallothioneins I+II; Zinc

Indexed keywords

METALLOTHIONEIN I; METALLOTHIONEIN II; ZINC ION;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD BRAIN BARRIER; BLOOD CEREBROSPINAL FLUID BARRIER; BRAIN; BRAIN HOMOGENATE; CEREBELLUM; CHRONIC DISEASE; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; IMMUNOHISTOCHEMISTRY; LIVER; MALE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RELAPSE; SPINAL CORD; UPREGULATION;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CATTLE; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; IMMUNOHISTOCHEMISTRY; LIVER; MALE; METALLOTHIONEIN; RATS; TIME FACTORS; UP-REGULATION; ZINC;

EID: 84882775353     PISSN: 18746098     EISSN: 18746128     Source Type: Journal    
DOI: 10.2174/1874609811306010006     Document Type: Article

References (56)

1. Baxter AG. The origin and application of experimental autoimmune encephalomyelitis. Nat Rev Immunol 2007; 7(11): 904-12.
2. El Behi M, Dubucquoi S, Lefranc D, et al. New insights into cell responses involved in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol Lett 2005; 96(1): 11-26.
3. Holmoy T. The immunology of multiple sclerosis: disease mechanisms and therapeutic targets. Minerva Med 2008; 99(2): 119-40.
4. Krishnamoorthy G and Wekerle H. EAE: an immunologist's magic eye. Eur J Immunol 2009; 39(8): 2031-5.
5. Steinman L, Zamvil SS. How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis. Ann Neurol 2006; 60(1): 12-21.
6. Chung RS, West AK. A role for extracellular metallothioneins in CNS injury and repair. Neuroscience 2004; 123(3): 595-9.
7. Penkowa M. Metallothionein I + II expression and roles during neuropathology in the CNS. Dan Med Bull 2006; 53(2): 105-21.
8. Stankovic RK, Chung RS, Penkowa M. Metallothioneins I and II: neuroprotective significance during CNS pathology. Int J Biochem Cell Biol 2007; 39(3): 484-9.
9. Hidalgo J, Penkowa M, Espejo C, et al. Expression of metallothionein- I, -II, and -III in Alzheimer disease and animal models of neuroinflammation. Exp Biol Med (Maywood) 2006; 231(9): 1450-8.
10. Penkowa M, Florit S, Giralt M, et al. Metallothionein reduces central nervous system inflammation, neurodegeneration, and cell death following kainic acid-induced epileptic seizures. J Neurosci Res 2005; 79(4): 522-34.
11. Inoue K, Takano H, Shimada A and Satoh M. Metallothionein as an anti-inflammatory mediator. Mediators Inflamm 2009; 2009: 101659.
12. Dittmann J, Fung SJ, Vickers JC, Chuah MI, Chung RS and West AK. Metallothionein biology in the ageing and neurodegenerative brain. Neurotox Res 2005; 7(1-2): 87-93.
13. Chung RS, Hidalgo J, West AK. New insight into the molecular pathways of metallothionein-mediated neuroprotection and regeneration. J Neurochem 2008; 104(1): 14-20.
14. Chung RS, Penkowa M, Dittmann J, et al. Redefining the role of metallothionein within the injured brain: extracellular metallothioneins play an important role in the astrocyte-neuron response to injury. J Biol Chem 2008; 283(22): 15349-58.
15. West AK, Hidalgo J, Eddins D, Levin ED, Aschner M. Metallothionein in the central nervous system: Roles in protection, regeneration and cognition. Neurotoxicology 2008; 29(3): 489-503.
16. Pedersen MO, Jensen R, Pedersen DS, et al. Metallothionein-I+II in neuroprotection. Biofactors 2009; 35(4): 315-25.
17. Penkowa M. Metallothioneins are multipurpose neuroprotectants during brain pathology. FEBS J 2006; 273(9): 1857-70.
18. Coyle P, Philcox JC, Carey LC, Rofe AM. Metallothionein: the multipurpose protein. Cell Mol Life Sci 2002; 59(4): 627-47.
19. Miles AT, Hawksworth GM, Beattie JH, Rodilla V. Induction, regulation, degradation, and biological significance of mammalian metallothioneins. Crit Rev Biochem Mol Biol 2000; 35(1): 35-70.
20. Andrews GK. Regulation of metallothionein gene expression by oxidative stress and metal ions. Biochem Pharmacol 2000; 59(1): 95-104.
21. Kang YJ. Metallothionein redox cycle and function. Exp Biol Med (Maywood) 2006; 231(9): 1459-67.
22. Dziegiel P. Expression of metallothioneins in tumor cells. Pol J Pathol 2004; 55(1): 3-12.
23. Cherian MG, Kang YJ. Metallothionein and liver cell regeneration. Exp Biol Med (Maywood) 2006; 231(2): 138-44.
24. Jakovac H, Grebic D, Mrakovcic-Sutic I, et al. Metallothionein expression and tissue metal kinetics after partial hepatectomy in mice. Biol Trace Elem Res 2006; 114(1-3): 249-68.
25. Dutsch-Wicherek M, Sikora J, Tomaszewska R. The possible biological role of metallothionein in apoptosis. Front Biosci 2008; 13: 4029-38.
26. Dziegiel P, Dumanska M, Forgacz J, Wojna A, Zabel M. Intensity of apoptosis as related to the expression of metallothionein (MT), caspase-3 (cas-3) and Ki-67 antigen and the survival time of patients with primary colorectal adenocarcinomas. Rocz Akad Med Bialymst 2004; 49 (Suppl 1): 5-7.
27. Formigari A, Irato P, Santon A. Zinc, antioxidant systems and metallothionein in metal mediated-apoptosis: biochemical and cytochemical aspects. Comp Biochem Physiol C Toxicol Pharmacol 2007; 146(4): 443-59.
28. Jia G, Gu YQ, Chen KT, et al. Protective role of metallothionein (I/II) against pathological damage and apoptosis induced by dimethylarsinic acid. World J Gastroenterol 2004; 10(1): 91-5.
29. McAleer MF, Tuan RS. Metallothionein protects against severe oxidative stress-induced apoptosis of human trophoblastic cells. In Vitr Mol Toxicol 2001; 14(3): 219-31.
30. Shimoda R, Achanzar WE, Qu W, et al. Metallothionein is a potential negative regulator of apoptosis. Toxicol Sci 2003; 73(2): 294-300.
31. Wiese L, Kurtzhals JA, Penkowa M. Neuronal apoptosis, metallothionein expression and proinflammatory responses during cerebral malaria in mice. Exp Neurol 2006; 200(1): 216-26.
32. Murphy BJ, Kimura T, Sato BG, Shi Y, Andrews GK. Metallothionein induction by hypoxia involves cooperative interactions between metal-responsive transcription factor-1 and hypoxiainducible transcription factor-1alpha. Mol Cancer Res 2008; 6(3): 483-90.
33. Haq F, Mahoney M, Koropatnick J. Signaling events for metallothionein induction. Mutat Res 2003; 533(1-2): 211-26.
34. Carpene E, Andreani G, Isani G. Metallothionein functions and structural characteristics. J Trace Elem Med Biol 2007; 21(Suppl 1): 35-9.
35. Carrasco J, Adlard P, Cotman C, et al. Metallothionein-I and -III expression in animal models of Alzheimer disease. Neuroscience 2006; 143(4): 911-22.
36. Penkowa M, Hidalgo J. Metallothionein treatment reduces proinflammatory cytokines IL-6 and TNF-alpha and apoptotic cell death during experimental autoimmune encephalomyelitis (EAE). Exp Neurol 2001; 170(1): 1-14.
37. Penkowa M, Hidalgo J. Treatment with metallothionein prevents demyelination and axonal damage and increases oligodendrocyte precursors and tissue repair during experimental autoimmune encephalomyelitis. J Neurosci Res 2003; 72(5): 574-86.
38. Penkowa M, Espejo C, Martinez-Caceres EM, Montalban X, Hidalgo J. Increased demyelination and axonal damage in metallothionein I+II-deficient mice during experimental autoimmune encephalomyelitis. Cell Mol Life Sci 2003; 60(1): 185-97.
39. Wu L, Van Kaer L. Natural killer T cells and autoimmune disease. Curr Mol Med 2009; 9(1): 4-14.
40. Penkowa M, Espejo C, Ortega-Aznar A, Hidalgo J, Montalban X, Martinez Caceres EM. Metallothionein expression in the central nervous system of multiple sclerosis patients. Cell Mol Life Sci 2003; 60(6): 1258-66.
41. Penkowa M, Hidalgo J. Metallothionein I+II expression and their role in experimental autoimmune encephalomyelitis. Glia 2000; 32(3): 247-63.
42. Ballabh P, Braun A, Nedergaard M. The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis 2004; 16(1): 1-13.
43. Becher B, Bechmann I, Greter M. Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain. J Mol Med 2006; 84(7): 532-43.
44. Tonra JR. Cerebellar susceptibility to experimental autoimmune encephalomyelitis in SJL/J mice: potential interaction of immunology with vascular anatomy. Cerebellum 2002; 1(1): 57-68.
45. Spitsin S, Portocarrero C, Phares TW, et al. Early blood-brain barrier permeability in cerebella of PLSJL mice immunized with myelin basic protein. J Neuroimmunol 2008; 196(1-2): 8-15.
46. Centonze D, Muzio L, Rossi S, et al. Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis. J Neurosci 2009; 29(11): 3442-52.
47. Alvarez-Buylla A, Lim DA. For the long run: maintaining germinal niches in the adult brain. Neuron 2004; 41(5): 683-6.
48. Lledo PM, Alonso M, Grubb MS. Adult neurogenesis and functional plasticity in neuronal circuits. Nat Rev Neurosci 2006; 7(3): 179-93.
49. Madri JA. Modeling the neurovascular niche: implications for recovery from CNS injury. J Physiol Pharmacol 2009; 60 (Suppl 4): 95-104.
50. Zajonc DM, Maricic I, Wu D, et al. Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity. J Exp Med 2005; 202(11): 1517-26.
51. Bendelac A, Savage PB and Teyton L. The biology of NKT cells. Annu Rev Immunol 2007; 25(297-336.
52. Santodomingo-Garzon T, Han J, Le T, Yang Y, Swain MG. Natural killer T cells regulate the homing of chemokine CXC receptor 3-positive regulatory T cells to the liver in mice. Hepatology 2009; 49(4): 1267-76.
53. Gabbi C, Warner M, Gustafsson JA. Minireview: liver X receptor beta: emerging roles in physiology and diseases. Mol Endocrinol 2009; 23(2): 129-36.
54. Xu J, Wagoner G, Douglas JC, Drew PD. Liver X receptor agonist regulation of Th17 lymphocyte function in autoimmunity. J Leukoc Biol 2009; 86(2): 401-9.
55. Mocchegiani E, Giacconi R, Cipriano C, Malavolta M. NK and NKT cells in aging and longevity: role of zinc and metallothioneins. J Clin Immunol 2009; 29(4): 416-25.
56. Mocchegiani E, Giacconi R, Muti E, et al. Zinc, immune plasticity, aging, and successful aging: role of metallothionein. Ann N Y Acad Sci 2004; 1019 127-34.